Clinigen Group plc operates as a specialty pharmaceutical and services company. The company operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines in the Africa and Asia Pacific region.
Read More…
Industry, Sector and Symbol
Industry Drug Delivery
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1283-495010
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£456.90 million
Profitability
Miscellaneous
Employees849
Next Earnings DateN/A
OptionableNot Optionable
Clinigen Group (LON:CLIN) Frequently Asked Questions
What is Clinigen Group's stock symbol?
Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."
How often does Clinigen Group pay dividends? What is the dividend yield for Clinigen Group?
Clinigen Group announced a dividend on Thursday, September 19th. Stockholders of record on Thursday, November 7th will be given a dividend of GBX 4.75 per share on Friday, November 29th. This represents a dividend yield of 0.51%. The ex-dividend date of this dividend is Thursday, November 7th. This is a positive change from Clinigen Group's previous dividend of $1.95. The official announcement can be accessed at this link. View Clinigen Group's Dividend History.
How were Clinigen Group's earnings last quarter?
Clinigen Group PLC (LON:CLIN) announced its quarterly earnings data on Tuesday, February, 27th. The company reported $21.20 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $20.30 by $0.90. The company had revenue of $167.80 million for the quarter. View Clinigen Group's Earnings History.
What price target have analysts set for CLIN?
5 Wall Street analysts have issued 12-month target prices for Clinigen Group's stock. Their forecasts range from GBX 1,000 to GBX 1,640. On average, they expect Clinigen Group's stock price to reach GBX 1,295 in the next year. This suggests a possible upside of 48.9% from the stock's current price. View Analyst Price Targets for Clinigen Group.
What is the consensus analysts' recommendation for Clinigen Group?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.
Has Clinigen Group been receiving favorable news coverage?
Media stories about CLIN stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Clinigen Group earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Clinigen Group.
Who are some of Clinigen Group's key competitors?
Some companies that are related to Clinigen Group include Envista (NVST), Aurora Cannabis (ACB), Healthequity (HQY), Repligen (RGEN), Healthscope (HSO), Spark Therapeutics (ONCE), Arrowhead Pharmaceuticals (ARWR), SmileDirectClub (SDC), The Medicines (MDCO), bluebird bio (BLUE), Mirati Therapeutics (MRTX), LHC Group (LHCG), BioNTech (BNTX), United Therapeutics (UTHR) and BTG (BTGGF).
What other stocks do shareholders of Clinigen Group own?
Who are Clinigen Group's key executives?
Clinigen Group's management team includes the folowing people:
- Mr. Shaun Edward Chilton, CEO & Exec. Director (Age 51)
- Mr. Nicholas Keher, CFO & Director
- Ms. Debra Ainge, Chief Operating Officer
- Matt Parrish, Head of Investor Relations
- Mr. David Bryant, Director of Corp. Devel.
How do I buy shares of Clinigen Group?
Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Clinigen Group's stock price today?
One share of CLIN stock can currently be purchased for approximately GBX 869.50.
How big of a company is Clinigen Group?
What is Clinigen Group's official website?
How can I contact Clinigen Group?
Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.
MarketBeat Community Rating for Clinigen Group (LON CLIN)
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe CLIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
